PRA published a statement reminding firms that the deferred part of the Delegated Regulation (EU) 2019/981, which was published by EC on June 18, 2019, will come into effect on January 01, 2020. This may impact the calculation of the Solvency Capital Requirement (SCR). Delegated Regulation (EU) 2019/981 amends Delegated Regulation (EU) 2015/35, which supplements the Solvency II Directive (2009/138/EC).
The changes under discussion relate to:
- Standard Formula component loss-absorbing capacity of deferred tax (LACDT)
- Segmentation of non-life insurance and reinsurance obligations
- Standard deviations for the non-life premium and reserve risk sub-module
- Segmentation of Not Similar to Life Techniques (NSLT) health insurance and reinsurance obligations
- Standard deviations for the NSLT health premium and reserve risk sub-module
Among the changes made to LACDT, there will be a requirement that any increases in deferred tax assets after a stress event shall not be included within the calculation of the tax adjustment to the SCR, unless firms are able to demonstrate to the satisfaction of PRA that it is probable that future taxable profit will be available, against which that increase can be utilized (Article 207 2a in the revised delegated regulation). PRA notes that the change to LACDT regulations will also be relevant for firms that use a Partial Internal Model for the SCR, where LACDT is not included within the scope of that model.
Effective Date: January 01, 2020
Keywords: Europe, UK, Insurance, Reinsurance, Solvency II, SCR, Loss-Absorbing Capacity, Deferred Tax, Capital Requirements, Regulation 2019/981, Regulation 2015/35, EC, PRA
Previous ArticleIAIS Publishes Report on Observations from Its Peer Review Process
APRA has concluded its review of the comprehensive plans of authorized deposit-taking institutions for the assessment and management of loans with repayment deferrals.
ESAs (EBA, EIOPA, and ESMA) published the first joint report that assesses risks in the financial sector since the outbreak of the COVID-19 pandemic.
BoE and HM Treasury confirmed that the COVID Corporate Financing Facility (CCFF) will close for new purchases of commercial paper, with effect from March 23, 2021.
ECB published a decision allowing the euro area banks under its direct supervision to exclude certain central bank exposures from the leverage ratio.
ESAs launched a survey seeking feedback on the presentational aspects of product templates under the Sustainable Finance Disclosure Regulation (SFDR or Regulation 2019/2088).
ECB published input of the European System of Central Banks (ESCB) into the EBA feasibility report on reducing the reporting burden for banks in EU.
EC adopted a decision determining, for a limited period of time, that the regulatory framework applicable to central counterparties, or CCPs, in the UK and Northern Ireland is equivalent to the requirements laid down in the European Market Infrastructure Regulation (EMIR or Regulation 648/2012).
EBA has decided to phase out the guidelines on legislative and non-legislative moratoria of loan repayments, in accordance with the earlier specified end of September deadline.
EBA published an Opinion addressed to EC to raise awareness about the opportunity to clarify certain issues related to the definition of credit institution in the upcoming review of the Capital Requirements Directive and Regulation (CRD and CRR).
ECB finalized the guide on assessment methodology for the internal model method for calculating exposure to counterparty credit risk (CCR) and the advanced method for own funds requirements for credit valuation adjustment (A-CVA) risk.